Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now

You can switch off notifications anytime using browser settings.

There is compelling need to focus on Biosimilar from govt, patients' point of view: Kiran Mazumdar-Shaw

Copy URL

There is a compelling need to focus on Biosimilar from govt and patients' point of view. Biocon and Mylan are leading the way along with few others in the Biosimilars segment, says Kiran Mazumdar-Shaw of Biocon limited.

Join market mavens on 22 Nov to discuss how India can beat economic slowdown & reach $5 Trillion economy mark at ETMarkets Global Summit. Book your seats today
Have something to say? Post your comment

Other useful Links

Follow us on

Download et app

Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service